Approval of The AETOS Shoulder System is a latest addition to Smith+Nephew's Upper Extremity portfolio.

United Kingdom: On 12 June 2023, Smith & Nephew plc. have announced that they have received approval for AETOS Shoulder System to restore patients’ mobility and reduce the discomfort caused by arthritis in the shoulder. The AETOS Shoulder System is designed for anatomical and inverse shoulder substitution. The system highlights the AETOS meta stem which provides metaphyseal fixation with an in-lay collar for improved steadiness, bone preservation, and anatomical maintenance. The framework of AETOS Shoulder System is designed for surgeons who seek maximum flexibility to reconstruct the upper arm bone and shoulder socket, utilizing a streamlined and user-friendly system that emphasizes favorable patient results. Moreover, The AETOS Shoulder Solution is set to be exhibited at the San Diego Shoulder Institute's yearly shoulder seminar in Coronado, CA this week.

The field of Orthopedics is experiencing rapid growth in the area of complete total shoulder arthroplasty, with a projected 250,000 operations to be performed in the United States by 2025. The design of the AETOS Shoulder System aims to simplify the workflow in the operating room by reducing the number of steps needed for conversion and minimizing the instruments required for both primary anatomic and reverse arthroplasty procedures.  

According to the President of Global Orthopedics, Smith & Nephew plc., “This platform is the culmination of years of research and development and represents our commitment to providing healthcare professionals with the best possible technology for their patients. We are confident that this platform will further evolve the standard of care for shoulder surgery and are excited to see the impact it has on patient outcomes. Receiving FDA clearance for the AETOS Shoulder System is a major milestone for Smith+Nephew. This platform is the culmination of years of research and development and represents our commitment to providing healthcare professionals with the best possible technology for their patients. We are confident that this platform will further evolve the standard of care for shoulder surgery and are excited to see the impact it has on patient outcomes.”

According to TechSci Research, Approval of The AETOS Shoulder System from FDA has revolutionized the portfolio of Smith+Nephew which compliments their sports medicine shoulder repair and biologics solution. Smith+Nephew is a global medical technology company that concentrates on repair, regeneration, and replacement of soft and hard tissue. The AETOS Shoulder System utilizes advanced technology that has led to enhanced surgical results, decreased duration of surgery, and increased patient satisfaction. Moreover, approval of the shoulder system is also expected to increase the orthopedics devices market share value which can reach up to 22% of total generated revenue form the purchase of shoulder replacement devices.